Novel CMY-186 variant conferring cross-resistance to cefiderocol and ceftazidime/avibactam in Klebsiella pneumoniae from a critically ill patient during cefiderocol and ceftazidime/avibactam treatment
Stefano Amadesi, Milo Gatti, Matteo Rinaldi, Federico Pea, Pierluigi Viale, Paolo Gaibani
Topics & Concepts
Ceftazidime/avibactamKlebsiella pneumoniaeCeftazidimeCritically illMicrobiologyCephalosporinBiologyMedicineIntensive care medicinePseudomonas aeruginosaAntibioticsBacteriaEscherichia coliBiochemistryGeneGeneticsAntibiotic Resistance in BacteriaAntibiotic Use and ResistanceNosocomial Infections in ICU